Terveystalo Oyj Past Earnings Performance

Past criteria checks 0/6

Terveystalo Oyj's earnings have been declining at an average annual rate of -18.8%, while the Healthcare industry saw earnings growing at 12.2% annually. Revenues have been growing at an average rate of 9.4% per year.

Key information

-18.8%

Earnings growth rate

-18.8%

EPS growth rate

Healthcare Industry Growth	13.4%
Revenue growth rate	9.4%
Return on equity	-8.2%
Net Margin	-3.3%
Next Earnings Update	17 Jul 2024

Recent past performance updates

Recent updates

Terveystalo Oyj (HEL:TTALO) Is Due To Pay A Dividend Of €0.15

Apr 26

Terveystalo Oyj (HEL:TTALO) Will Pay A Dividend Of €0.15

Mar 29

Shareholders May Be Wary Of Increasing Terveystalo Oyj's (HEL:TTALO) CEO Compensation Package

Mar 20

An Intrinsic Calculation For Terveystalo Oyj (HEL:TTALO) Suggests It's 44% Undervalued

Jan 11

Terveystalo Oyj (HEL:TTALO) Seems To Use Debt Quite Sensibly

Nov 24

Revenue & Expenses Breakdown
Beta

How Terveystalo Oyj makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

HLSE:TTALO Revenue, expenses and earnings (EUR Millions)
Date	Revenue	Earnings	G+A Expenses
31 Dec 23	1,286	-42	9
30 Sep 23	1,279	30	10
30 Jun 23	1,275	7	12
31 Mar 23	1,271	10	11
31 Dec 22	1,259	24	9
30 Sep 22	1,252	43	12
30 Jun 22	1,249	77	14
31 Mar 22	1,206	82	11
31 Dec 21	1,155	81	7
30 Sep 21	1,107	77	11
30 Jun 21	1,074	79	4
31 Mar 21	1,008	61	4
31 Dec 20	986	46	5
30 Sep 20	977	40	8
30 Jun 20	971	34	8
31 Mar 20	1,020	46	8
31 Dec 19	1,031	54	7
30 Sep 19	958	48	19
30 Jun 19	885	54	26
31 Mar 19	815	59	34
31 Dec 18	745	69	41
30 Sep 18	737	65	45
30 Jun 18	732	42	45
31 Mar 18	727	29	53
31 Dec 17	690	7	42
30 Sep 17	646	9	38
30 Jun 17	610	16	35
31 Mar 17	567	16	22
31 Dec 16	547	13	30
31 Dec 15	506	1	31
31 Dec 14	474	-83	30

Quality Earnings: TTALO is currently unprofitable.

Growing Profit Margin: TTALO is currently unprofitable.

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: TTALO is unprofitable, and losses have increased over the past 5 years at a rate of 18.8% per year.

Accelerating Growth: Unable to compare TTALO's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: TTALO is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (4%).

Return on Equity

High ROE: TTALO has a negative Return on Equity (-8.19%), as it is currently unprofitable.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Terveystalo Oyj Past Earnings Performance

Past criteria checks 0/6

Key information

Recent past performance updates

Full year 2023 earnings released: €0.33 loss per share (vs €0.19 profit in FY 2022)

Third quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Terveystalo Oyj to Report Q1, 2024 Results on Apr 26, 2024

Second quarter 2023 earnings: EPS and revenues miss analyst expectations

First quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Full year 2022 earnings: EPS misses analyst expectations

Recent updates

Terveystalo Oyj (HEL:TTALO) Is Due To Pay A Dividend Of €0.15

Terveystalo Oyj (HEL:TTALO) Will Pay A Dividend Of €0.15

Dividend of €0.15 announced

Terveystalo Oyj Announces Election of Teija Sarajärvi as Member of Remuneration Committee

Terveystalo Oyj Elects Teija Sarajärvi as Member of the Board

Upcoming dividend of €0.15 per share

Shareholders May Be Wary Of Increasing Terveystalo Oyj's (HEL:TTALO) CEO Compensation Package

Tuomas Rissanen and Heidi Boman members of Sivupersoona management signed an agreement to acquire Sivupersoona Oy from Terveystalo Oyj (HLSE:TTALO) in a management buyout transaction.

Full year 2023 earnings released: €0.33 loss per share (vs €0.19 profit in FY 2022)

Terveystalo Oyj's (HEL:TTALO) Dividend Will Be Increased To €0.15

New major risk - Financial position

Terveystalo plc Provides Earnings Guidance for 2024

Terveystalo plc Proposes Dividend for 2023 in Two Installments, Payable on April 8, 2024, and October 16, 2024, Respectively

Consensus EPS estimates fall by 42%

Does Terveystalo Oyj (HEL:TTALO) Have A Healthy Balance Sheet?

Investors Appear Satisfied With Terveystalo Oyj's (HEL:TTALO) Prospects

Terveystalo Oyj Announces Non Availability of Katri Viippola for Re-Election to the Board of Directors

Consensus EPS estimates fall by 13%

Terveystalo Oyj Announces Management Changes

We Think Terveystalo Oyj (HEL:TTALO) Can Stay On Top Of Its Debt

Third quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Terveystalo Oyj to Report Q1, 2024 Results on Apr 26, 2024

Upcoming dividend of €0.14 per share at 3.5% yield

New major risk - Financial position

Terveystalo Oyj Provides Revenue Guidance for the Year 2023

Second quarter 2023 earnings: EPS and revenues miss analyst expectations

Terveystalo Oyj (HEL:TTALO) Will Pay A Dividend Of €0.14

Terveystalo Oyj (HEL:TTALO) Is Paying Out A Dividend Of €0.14

Terveystalo Oyj (HEL:TTALO) Has Affirmed Its Dividend Of €0.14

First quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

High number of new directors

Terveystalo Oyj (HEL:TTALO) Has Announced A Dividend Of €0.14

Upcoming dividend of €0.14 per share at 4.1% yield

Full year 2022 earnings: EPS misses analyst expectations

Terveystalo Oyj Proposes Dividend for the Financial Year Ended 31 December 2022, Payable on 3 April 2023 and 9 October 2023

Price target increased by 7.3% to €9.22

Is Terveystalo Oyj (HEL:TTALO) Using Too Much Debt?

Terveystalo Oyj Announces Board Elections

Price target decreased to €8.59

Price target decreased to €8.59

Terveystalo Oyj (HLSE:TTALO) acquired Somia Reality Oy.

Terveystalo Oyj, Annual General Meeting, Mar 23, 2023

Terveystalo Oyj to Report Q1, 2023 Results on Apr 28, 2023

Third quarter 2022 earnings: EPS misses analyst expectations

Terveystalo Oyj to Report Fiscal Year 2022 Results on Feb 10, 2023

Consensus EPS estimates fall by 35%

Investor sentiment deteriorated over the past week

Terveystalo Oyj Announces Changes in Executive Team

Upcoming dividend of €0.14 per share

Terveystalo Plc Board Member Dag Andersson Passed Away

Is Terveystalo Oyj (HEL:TTALO) Using Too Much Debt?

Terveystalo Oyj Announces Composition of Shareholders Nomination Board

Terveystalo Oyj (HLSE:TTALO) acquired Ludus Oy Tutkimus- ja Kuntoutuspalvelut.

Terveystalo Oyj (HLSE:TTALO) acquired Ludus Oy Tutkimus- ja Kuntoutuspalvelut.

Consensus forecasts updated

Price target decreased to €11.35

Should You Investigate Terveystalo Oyj (HEL:TTALO) At €9.52?

Second quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Terveystalo Oyj Appoints Juuso Pajunen, B. 1981, M.Sc. (Econ.) as Member of the Executive Team

Terveystalo Oyj (HLSE:TTALO) acquired Kunnon Syke Oy.

Terveystalo Plc Announces Nomination Board Changes

Terveystalo Oyj (HLSE:TTALO) acquired Into Terveys Oy.

Here's Why I Think Terveystalo Oyj (HEL:TTALO) Is An Interesting Stock

First quarter 2022 earnings: EPS and revenues exceed analyst expectations

Is Terveystalo Oyj (HEL:TTALO) A Risky Investment?

Terveystalo Oyj Announces Board Changes

Terveystalo Oyj (HLSE:TTALO) acquired Suomen Fysiogeriatria Oy.

Upcoming dividend of €0.14 per share

Terveystalo Oyj (HLSE:TTALO) acquired Omt-klinikka Kokkola Oy.

Revenue & Expenses Breakdown
Beta